These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8743644)

  • 1. A target-dose finding study of clozapine in patients with schizophrenia.
    Bennett JA; Keck PE
    Ann Clin Psychiatry; 1996 Mar; 8(1):19-21. PubMed ID: 8743644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical use of clozapine plasma concentrations in the management of treatment-refractory schizophrenia.
    Miller DD
    Ann Clin Psychiatry; 1996 Jun; 8(2):99-109. PubMed ID: 8807035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvoxamine reduces the clozapine dosage needed in refractory schizophrenic patients.
    Lu ML; Lane HY; Chen KP; Jann MW; Su MH; Chang WH
    J Clin Psychiatry; 2000 Aug; 61(8):594-9. PubMed ID: 10982203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neuroleptics.
    Spina E; Avenoso A; Facciolà G; Scordo MG; Ancione M; Madia AG; Ventimiglia A; Perucca E
    Psychopharmacology (Berl); 2000 Jan; 148(1):83-9. PubMed ID: 10663421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
    Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
    J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.
    Perry PJ; Bever KA; Arndt S; Combs MD
    Biol Psychiatry; 1998 Oct; 44(8):733-8. PubMed ID: 9798077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unanticipated plasma concentrations in two clozapine-treated patients.
    Alfaro CL; McClure RK; Vertrees JE; Benavides R
    Ann Pharmacother; 2001 Sep; 35(9):1028-31. PubMed ID: 11573850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence of clozapine orally disintegrating 100-mg tablets compared with clozapine solid oral 100-mg tablets after multiple doses in patients with schizophrenia.
    Golden G; Honigfeld G
    Clin Drug Investig; 2008; 28(4):231-9. PubMed ID: 18345713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients.
    Perry PJ; Miller DD; Arndt SV; Cadoret RJ
    Am J Psychiatry; 1991 Feb; 148(2):231-5. PubMed ID: 1670979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine dosages and plasma drug concentrations.
    Chang WH; Lin SK; Lane HY; Hu WH; Jann MW; Lin HN
    J Formos Med Assoc; 1997 Aug; 96(8):599-605. PubMed ID: 9290269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical predictors of serum clozapine levels in patients with treatment-resistant schizophrenia.
    Rajkumar AP; Poonkuzhali B; Kuruvilla A; Jacob M; Jacob KS
    Int Clin Psychopharmacol; 2013 Jan; 28(1):50-6. PubMed ID: 23104241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
    Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
    J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and biochemical correlates of "high-dose" clozapine therapy for treatment-refractory schizophrenia.
    Buckley PF; Friedman L; Krowinski AC; Eaton Y; Tronetti M; Miller DD
    Schizophr Res; 2001 Apr; 49(1-2):225-7. PubMed ID: 11428347
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma concentrations of high-dose olanzapine in a double-blind crossover study.
    Kelly DL; Richardson CM; Yu Y; Conley RR
    Hum Psychopharmacol; 2006 Aug; 21(6):393-8. PubMed ID: 16850522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.
    Zoccali R; Muscatello MR; Torre DL; Malara G; Canale A; Crucitti D; D'Arrigo C; Spina E
    Pharmacol Res; 2003 Oct; 48(4):411-4. PubMed ID: 12902213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma clozapine concentration coefficients of variation in a long-term study.
    Diaz FJ; de Leon J; Josiassen RC; Cooper TB; Simpson GM
    Schizophr Res; 2005 Jan; 72(2-3):131-5. PubMed ID: 15560958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients.
    Consoli G; Lastella M; Ciapparelli A; Catena Dell'Osso M; Ciofi L; Guidotti E; Danesi R; Dell'Osso L; Del Tacca M; Di Paolo A
    Pharmacogenomics; 2009 Aug; 10(8):1267-76. PubMed ID: 19663671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seizure on low-dose clozapine.
    Ravasia S; Dickson RA
    Can J Psychiatry; 1998 May; 43(4):420. PubMed ID: 9598281
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma levels of clozapine and norclozapine in Mexican schizophrenia patients.
    González-Esquivel DF; Castro N; Ramírez-Bermúdez J; Custodio V; Rojas-Tomé S; Castro-Román R; Jung-Cook H
    Arzneimittelforschung; 2011; 61(6):335-9. PubMed ID: 21827043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels.
    Aymard N; Baldacci C; Leyris A; Smagghe PO; Tribolet S; Vacheron MN; Viala A; Caroli F
    Therapie; 1997; 52(3):227-32. PubMed ID: 9366107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.